Howard Capital Management Inc. Acquires 348 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Howard Capital Management Inc. increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,293 shares of the medical equipment provider’s stock after acquiring an additional 348 shares during the quarter. Howard Capital Management Inc.’s holdings in Intuitive Surgical were worth $5,373,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the fourth quarter worth $26,000. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical during the third quarter worth $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the fourth quarter worth $36,000. Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the third quarter worth $38,000. Finally, DT Investment Partners LLC lifted its holdings in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 36 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock worth $3,587,582 in the last ninety days. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Down 2.4 %

Shares of NASDAQ ISRG opened at $591.79 on Friday. The firm has a market capitalization of $210.78 billion, a P/E ratio of 92.32, a P/E/G ratio of 5.85 and a beta of 1.39. The stock’s 50-day simple moving average is $565.45 and its two-hundred day simple moving average is $525.06. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of recent research reports. Bernstein Bank raised their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. UBS Group raised their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Finally, Barclays raised their target price on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.